METHIONINE EFFECTS ON CHRONIC SCHIZOPHRENICS: PATIENTS TREATED WITH MONOAMINE OXIDASE INHIBITORS.
D035843:Biomedical Research; D004357:Drug Synergism; D004358:Drug Therapy; D005998:Glycine; D007490:Iproniazid; D007520:Isocarboxazid; D001523:Mental Disorders; D008715:Methionine; D008996:Monoamine Oxidase Inhibitors; D010919:Placebos; D011605:Psychoses, Substance-Induced; D011618:Psychotic Disorders; D012559:Schizophrenia; D014116:Toxicology
D008996:Monoamine Oxidase Inhibitors; D010919:Placebos; D007520:Isocarboxazid; D008715:Methionine; D007490:Iproniazid; D005998:Glycine
CLINICAL RESEARCH; DRUG SYNERGISM; DRUG THERAPY; GLYCINE; IPRONIAZID; ISOCARBOXAZID; METHIONINE; PLACEBOS; PSYCHOSES, TOXIC; SCHIZOPHRENIA; TOXICOLOGIC REPORT